Each year, around 100,000 people in the UK lose their lives to heart attacks. Many of these deaths happen before the ambulance arrives.
One major reason is a problem called ischemia, where the heart muscle doesn’t get enough blood and oxygen because of a blocked artery.
This can lead to a life-threatening problem called ventricular fibrillation, or VF, where the heart beats in a very abnormal way. VF can quickly cause sudden death if not treated right away.
Doctors have known about medicines that might help stop VF, but many of them are too dangerous to use outside hospitals. One of these is lidocaine. It can stop VF, but it also affects the whole body, including the brain and other parts of the heart. Because of these strong side effects, doctors only give lidocaine through an I.V. in hospitals.
Now, a new study from King’s College London has discovered a new drug that could change everything. The drug is called OCT2013. It was designed to act like lidocaine but without the harmful effects. Scientists tested this drug in rats that were given heart attacks in a lab setting. What they found was very promising.
OCT2013 is special because it only becomes active in the areas of the heart that are low in oxygen. These areas are where ischemia is happening. In simple terms, the drug “wakes up” only where it’s needed. Everywhere else in the body, it stays inactive. This helps avoid the side effects seen with lidocaine.
When OCT2013 reaches the parts of the heart suffering from ischemia, it turns into lidocaine. This action helps to steady the heart’s electrical signals and stop dangerous heart rhythms like VF. Because it only works in certain areas, OCT2013 does not disturb other parts of the body. This makes it much safer than older drugs.
The scientists behind this research believe that OCT2013 could be used outside hospitals in the future. This would be a big step forward. People having a heart attack might be able to take this drug before they reach the hospital, which could save many lives.
The study was led by Dr. Mike Curtis and published in the British Journal of Pharmacology. It offers new hope in fighting sudden death from heart attacks. It also shows how smart drug design can help make treatments that work only where and when they are needed.
By reducing the risk of sudden death without the danger of serious side effects, OCT2013 could become a powerful new tool in heart care. It could also pave the way for other new medicines that work in a similar targeted way.
This exciting discovery shows that we are moving closer to finding safer and more effective ways to protect the heart during emergencies.
If you care about heart health, please read studies about how vitamin D influences cholesterol levels, and what we know about egg intake and heart disease.
For more health information, please see recent studies about best supplements for heart disease prevention, and wild blueberries can benefit your heart and brain.
Copyright © 2025 Knowridge Science Report. All rights reserved.
